ENT Technologies has launched a new three year partnership with Asthma Australia, which will see the organisations work together to improve the respiratory health of Australians with asthma.
ENT manufactures the Flo range of nasal sprays and washes, with the company's founder and medical director, Sam Barbalatt, saying "we know that our products and philosophy greatly align with Asthma Australia's mission.
"Looking after nasal health is an important part of looking after the respiratory system," he said, noting that all Flo saline products are preservative free and suitable for people with asthma.
The new partnership will see ENT provide funding support to Asthma Australia, as well as training asthma educators on the benefits of maintaining nasal health for people with asthma and hay fever.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Jul 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Jul 18
